Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 139.55%75.51M | 104.43%56.19M | 42.98%129.46M | 58.94%39.64M | 47.18%30.8M | 46.23%31.52M | 18.87%27.49M | -31.85%90.54M | -2.51%24.94M | -40.69%20.93M |
| Cost of revenue | 158.40%67.22M | 122.81%49.92M | 41.51%107.94M | 69.44%33.78M | 43.22%25.92M | 41.61%26.01M | 12.76%22.41M | -36.85%76.28M | -19.33%19.94M | -43.33%18.1M |
| Gross profit | 50.50%8.29M | 23.37%6.27M | 50.80%21.51M | 17.09%5.86M | 72.47%4.88M | 72.85%5.51M | 56.16%5.08M | 18.18%14.26M | 477.13%5M | -15.50%2.83M |
| Operating expense | 85.35%6.97M | 31.98%5.03M | 26.95%17.2M | 50.07%6.1M | 66.51%4.25M | 21.47%3.76M | -79.45%3.81M | -24.50%13.55M | 6.83%4.06M | -44.57%2.55M |
| Staff costs | ---- | ---- | 0.45%8.75M | ---- | ---- | ---- | ---- | -7.01%8.71M | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | 215.62%5.21M | ---- | ---- | ---- | ---- | -67.81%1.65M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | 232.12%2.37M | ---- | ---- | ---- | ---- | -62.50%713.46K | ---- | ---- |
| -General and administrative expense | ---- | ---- | 203.03%2.84M | ---- | ---- | ---- | ---- | -70.95%935.79K | ---- | ---- |
| Depreciation and amortization | ---- | ---- | 1.65%3.17M | ---- | ---- | ---- | ---- | -6.98%3.12M | ---- | ---- |
| -Depreciation | ---- | ---- | 1.65%3.17M | ---- | ---- | ---- | ---- | -6.98%3.12M | ---- | ---- |
| Rent and land expenses | ---- | ---- | 7.71%75.3K | ---- | ---- | ---- | ---- | -31.16%69.9K | ---- | ---- |
| Other operating expenses | 85.35%6.97M | 31.98%5.03M | -36.57%17.91M | 50.07%6.1M | 66.51%4.25M | 21.47%3.76M | -79.45%3.81M | --28.24M | --4.06M | -44.57%2.55M |
| Operating profit | -24.64%1.32M | -2.44%1.24M | 504.76%4.31M | -125.29%-238K | 126.79%635K | 1,860.67%1.75M | 108.32%1.27M | 112.11%712.02K | 132.06%941K | 122.38%280K |
| Net non-operating interest income (expenses) | -23.75%-198K | -28.32%-222K | 40.59%-563.7K | -119.42%-226K | 77.03%-150K | 0.62%-160K | -1.17%-173K | 75.07%-948.79K | 97.16%-103K | -1,260.42%-653K |
| Non-operating interest income | ---- | ---- | 4.23%144.97K | ---- | ---- | ---- | ---- | 348.88%139.08K | ---- | ---- |
| Non-operating interest expense | 23.75%198K | 28.32%222K | -34.86%708.67K | 119.42%226K | -77.03%150K | -0.62%160K | 1.17%173K | -71.65%1.09M | -97.19%103K | 1,260.42%653K |
| Net investment income | 68.27%45.47K | -90.31%27.02K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 3,018.32%5.38M | -184.18K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -134.02%-672.44K | 44.52%1.98M | ||||||||
| Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -2,678.00%-8.67M | ---- | ---- |
| Less:Impairment of capital assets | ---- | ---- | 1,439.60%195.7K | ---- | ---- | ---- | ---- | -85.44%12.71K | ---- | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 283.30%15.17M | ---- | ---- |
| Less:Write off | ---- | ---- | 105.62%476.74K | ---- | ---- | ---- | ---- | -1,281.55%-8.49M | ---- | ---- |
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | 905.56%362K | 117.78%196K | -17.59%905.67K | 274.95%6.52M | -99.81%39K | -90.06%36K | -43.40%90K | 126.41%1.1M | 45.64%-3.73M | 192.47%20.95M |
| Income before tax | -8.76%1.48M | 2.19%1.21M | 250.38%9.4M | 309.62%6.06M | -97.45%524K | 458.97%1.62M | 107.77%1.19M | 135.50%2.68M | 75.46%-2.89M | 250.91%20.57M |
| Income tax | 10.20%594K | 10.90%519K | 75.95%1.59M | -0.83%239K | 22.22%341K | 82.71%539K | 420.00%468K | 21.82%904.72K | -67.85%241K | 472.00%279K |
| Net income | -18.21%885K | -3.47%695K | 339.19%7.8M | 285.85%5.82M | -99.10%183K | 21,740.00%1.08M | 104.68%720K | 121.42%1.78M | 75.01%-3.13M | 241.78%20.3M |
| Net income continuous operations | -18.21%885K | -3.47%695K | 339.19%7.8M | 285.85%5.82M | -99.10%183K | 21,740.00%1.08M | 104.68%720K | 121.42%1.78M | 75.01%-3.13M | 241.78%20.3M |
| Noncontrolling interests | 81.43%127K | 82.98%-16K | 104.77%29.1K | 187.38%443K | -286.14%-390K | 2,433.33%70K | -3,233.33%-94K | -59,477.90%-609.81K | -5,716.48%-507K | -1,583.33%-101K |
| Net income attributable to the company | -25.10%758K | -12.65%711K | 225.76%7.78M | 304.88%5.38M | -97.19%573K | 50,700.00%1.01M | 105.29%814K | 128.76%2.39M | 79.07%-2.62M | 243.14%20.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.10%758K | -12.65%711K | 225.76%7.78M | 304.88%5.38M | -97.19%573K | 50,700.00%1.01M | 105.29%814K | 128.76%2.39M | 79.07%-2.62M | 243.14%20.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -67.74%0.0004 | -63.13%0.0004 | 124.11%0.0066 | 265.90%0.0054 | -97.28%0.0007 | 41,433.33%0.0012 | 105.56%0.0011 | 125.33%0.0029 | 81.58%-0.0033 | 207.38%0.0257 |
| Diluted earnings per share | -67.74%0.0004 | -63.13%0.0004 | 124.11%0.0066 | 265.90%0.0054 | -97.28%0.0007 | 41,433.33%0.0012 | 105.56%0.0011 | 125.33%0.0029 | 81.58%-0.0033 | 207.38%0.0257 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.